Medistep Healthcare H1 FY27 Results: Net Profit ₹3.1 Cr, Up 3.3% YoY
Medistep Healthcare Ltd reported revenue from operations of ₹37.4 Cr (+6.6% YoY) and net profit of ₹3.1 Cr (+3.3% YoY) for H1 FY27.
- Key figure
- Net profit ₹3.1 Cr · +3.3% YoY
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Medistep Healthcare Ltd reported revenue from operations of ₹37.4 Cr (+6.6% YoY) and net profit of ₹3.1 Cr (+3.3% YoY) for H1 FY27.
Medistep Healthcare Limited has submitted the compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Medistep Healthcare Limited held its 3rd Annual General Meeting on September 17, 2026. Shareholders transacted on financial statements, director re-appointment, and investment thresholds.
Medistep Healthcare Limited has appointed M/s. Kapil Kumar Agarwal & Associates as Internal Auditor and M/s. Vaibhav Sharma & Associates as Secretarial Auditor.
Medistep Healthcare Limited announced the outcome of its board meeting held on August 24, 2026. Key decisions include notice for the AGM and appointment of auditors.
Medistep Healthcare Limited has issued a notice for its 3rd Annual General Meeting (AGM) to be held on September 17, 2026. The filing includes the company's annual report.
Medistep Healthcare is incorporating a wholly owned subsidiary, Genicus Healthcare Private Limited. The new entity will manufacture nutraceuticals and allopathic products in India.
Medistep Healthcare Ltd reported revenue from operations of ₹35.8 Cr (+26.1% YoY) and net profit of ₹3 Cr (+20.0% YoY) for H2 FY26.
Medistep Healthcare Limited reported a total income of ₹70.83 Crore for FY2026. The Board approved these audited standalone results alongside an unmodified auditor's opinion.
Medistep Healthcare scheduled a board meeting for May 26, 2026, to approve audited annual financial results. The trading window remains closed for designated persons.